The Market Reports

Index

1 Market Overview
1.1 Product Overview and Scope of Novel Coronavirus (COVID-19) Vaccine
1.2 Classification of Novel Coronavirus (COVID-19) Vaccine by Type
1.2.1 Overview: Global Novel Coronavirus (COVID-19) Vaccine Market Size by Type: 2022 Versus 2028
1.2.2 Global Novel Coronavirus (COVID-19) Vaccine Revenue Market Share by Type in 2028
1.2.3 DNA
1.2.4 RNA
1.2.5 Others
1.3 Global Novel Coronavirus (COVID-19) Vaccine Market by Application
1.3.1 Overview: Global Novel Coronavirus (COVID-19) Vaccine Market Size by Application: 2022 Versus 2028
1.3.2 Mild Symptom Patient
1.3.3 Critically Ill Patient
1.4 Global Novel Coronavirus (COVID-19) Vaccine Market Size & Forecast
1.5 Market Drivers, Restraints and Trends
1.5.1 Novel Coronavirus (COVID-19) Vaccine Market Drivers
1.5.2 Novel Coronavirus (COVID-19) Vaccine Market Restraints
1.5.3 Novel Coronavirus (COVID-19) Vaccine Trends Analysis
2 Company Profiles
2.1 Inovio Pharmaceuticals
2.1.1 Inovio Pharmaceuticals Details
2.1.2 Inovio Pharmaceuticals Major Business
2.1.3 Inovio Pharmaceuticals Novel Coronavirus (COVID-19) Vaccine Product and Solutions
2.1.4 Inovio Pharmaceuticals Recent Developments and Future Plans
2.2 Takis Biotech (Evvivax)
2.2.1 Takis Biotech (Evvivax) Details
2.2.2 Takis Biotech (Evvivax) Major Business
2.2.3 Takis Biotech (Evvivax) Novel Coronavirus (COVID-19) Vaccine Product and Solutions
2.2.4 Takis Biotech (Evvivax) Recent Developments and Future Plans
2.3 Zydus Cadila
2.3.1 Zydus Cadila Details
2.3.2 Zydus Cadila Major Business
2.3.3 Zydus Cadila Novel Coronavirus (COVID-19) Vaccine Product and Solutions
2.3.4 Zydus Cadila Recent Developments and Future Plans
2.4 Codagenix, Inc.
2.4.1 Codagenix, Inc. Details
2.4.2 Codagenix, Inc. Major Business
2.4.3 Codagenix, Inc. Novel Coronavirus (COVID-19) Vaccine Product and Solutions
2.4.4 Codagenix, Inc. Recent Developments and Future Plans
2.5 GeoVax, Inc.
2.5.1 GeoVax, Inc. Details
2.5.2 GeoVax, Inc. Major Business
2.5.3 GeoVax, Inc. Novel Coronavirus (COVID-19) Vaccine Product and Solutions
2.5.4 GeoVax, Inc. Recent Developments and Future Plans
2.6 Bravovax
2.6.1 Bravovax Details
2.6.2 Bravovax Major Business
2.6.3 Bravovax Novel Coronavirus (COVID-19) Vaccine Product and Solutions
2.6.4 Bravovax Recent Developments and Future Plans
2.7 Janssen Pharmaceutical Companies
2.7.1 Janssen Pharmaceutical Companies Details
2.7.2 Janssen Pharmaceutical Companies Major Business
2.7.3 Janssen Pharmaceutical Companies Novel Coronavirus (COVID-19) Vaccine Product and Solutions
2.7.4 Janssen Pharmaceutical Companies Recent Developments and Future Plans
2.8 Altimmune
2.8.1 Altimmune Details
2.8.2 Altimmune Major Business
2.8.3 Altimmune Novel Coronavirus (COVID-19) Vaccine Product and Solutions
2.8.4 Altimmune Recent Developments and Future Plans
2.9 Vaxart
2.9.1 Vaxart Details
2.9.2 Vaxart Major Business
2.9.3 Vaxart Novel Coronavirus (COVID-19) Vaccine Product and Solutions
2.9.4 Vaxart Recent Developments and Future Plans
2.10 CanSino Biologics
2.10.1 CanSino Biologics Details
2.10.2 CanSino Biologics Major Business
2.10.3 CanSino Biologics Novel Coronavirus (COVID-19) Vaccine Product and Solutions
2.10.4 CanSino Biologics Recent Developments and Future Plans
2.11 ExpreS2ion Biotechnologies ApS
2.11.1 ExpreS2ion Biotechnologies ApS Details
2.11.2 ExpreS2ion Biotechnologies ApS Major Business
2.11.3 ExpreS2ion Biotechnologies ApS Novel Coronavirus (COVID-19) Vaccine Product and Solutions
2.11.4 ExpreS2ion Biotechnologies ApS Recent Developments and Future Plans
2.12 Clover Biopharmaceuticals
2.12.1 Clover Biopharmaceuticals Details
2.12.2 Clover Biopharmaceuticals Major Business
2.12.3 Clover Biopharmaceuticals Novel Coronavirus (COVID-19) Vaccine Product and Solutions
2.12.4 Clover Biopharmaceuticals Recent Developments and Future Plans
2.13 GSK
2.13.1 GSK Details
2.13.2 GSK Major Business
2.13.3 GSK Novel Coronavirus (COVID-19) Vaccine Product and Solutions
2.13.4 GSK Recent Developments and Future Plans
2.14 Vaxil Bio Ltd.
2.14.1 Vaxil Bio Ltd. Details
2.14.2 Vaxil Bio Ltd. Major Business
2.14.3 Vaxil Bio Ltd. Novel Coronavirus (COVID-19) Vaccine Product and Solutions
2.14.4 Vaxil Bio Ltd. Recent Developments and Future Plans
2.15 Generex
2.15.1 Generex Details
2.15.2 Generex Major Business
2.15.3 Generex Novel Coronavirus (COVID-19) Vaccine Product and Solutions
2.15.4 Generex Recent Developments and Future Plans
2.16 Novavax, Inc.
2.16.1 Novavax, Inc. Details
2.16.2 Novavax, Inc. Major Business
2.16.3 Novavax, Inc. Novel Coronavirus (COVID-19) Vaccine Product and Solutions
2.16.4 Novavax, Inc. Recent Developments and Future Plans
2.17 Sanofi Pasteur
2.17.1 Sanofi Pasteur Details
2.17.2 Sanofi Pasteur Major Business
2.17.3 Sanofi Pasteur Novel Coronavirus (COVID-19) Vaccine Product and Solutions
2.17.4 Sanofi Pasteur Recent Developments and Future Plans
2.18 Baylor
2.18.1 Baylor Details
2.18.2 Baylor Major Business
2.18.3 Baylor Novel Coronavirus (COVID-19) Vaccine Product and Solutions
2.18.4 Baylor Recent Developments and Future Plans
2.19 iBio, Inc.
2.19.1 iBio, Inc. Details
2.19.2 iBio, Inc. Major Business
2.19.3 iBio, Inc. Novel Coronavirus (COVID-19) Vaccine Product and Solutions
2.19.4 iBio, Inc. Recent Developments and Future Plans
2.20 Moderna, Inc.
2.20.1 Moderna, Inc. Details
2.20.2 Moderna, Inc. Major Business
2.20.3 Moderna, Inc. Novel Coronavirus (COVID-19) Vaccine Product and Solutions
2.20.4 Moderna, Inc. Recent Developments and Future Plans
2.21 Curevac
2.21.1 Curevac Details
2.21.2 Curevac Major Business
2.21.3 Curevac Novel Coronavirus (COVID-19) Vaccine Product and Solutions
2.21.4 Curevac Recent Developments and Future Plans
2.22 ImmunoPrecise
2.22.1 ImmunoPrecise Details
2.22.2 ImmunoPrecise Major Business
2.22.3 ImmunoPrecise Novel Coronavirus (COVID-19) Vaccine Product and Solutions
2.22.4 ImmunoPrecise Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Novel Coronavirus (COVID-19) Vaccine Revenue and Share by Players (2022 & 2028)
3.2 Novel Coronavirus (COVID-19) Vaccine Players Head Office, Products and Services Provided
3.3 Novel Coronavirus (COVID-19) Vaccine Mergers & Acquisitions
3.4 Novel Coronavirus (COVID-19) Vaccine New Entrants and Expansion Plans
4 Global Novel Coronavirus (COVID-19) Vaccine Forecast by Region
4.1 Global Novel Coronavirus (COVID-19) Vaccine Market Size by Region: 2022 VS 2028
4.2 Global Novel Coronavirus (COVID-19) Vaccine Market Size by Region, (2022-2028)
4.3 North America
4.3.1 Key Companies of Novel Coronavirus (COVID-19) Vaccine in North America
4.3.2 Current Situation and Forecast of Novel Coronavirus (COVID-19) Vaccine in North America
4.3.3 North America Novel Coronavirus (COVID-19) Vaccine Market Size and Prospect (2022-2028)
4.4 Europe
4.4.1 Key Companies of Novel Coronavirus (COVID-19) Vaccine in Europe
4.4.2 Current Situation and Forecast of Novel Coronavirus (COVID-19) Vaccine in Europe
4.4.3 Europe Novel Coronavirus (COVID-19) Vaccine Market Size and Prospect (2022-2028)
4.5 Asia-Pacific
4.5.1 Key Companies of Novel Coronavirus (COVID-19) Vaccine in Asia-Pacific
4.5.2 Current Situation and Forecast of Novel Coronavirus (COVID-19) Vaccine in Asia-Pacific
4.5.3 Asia-Pacific Novel Coronavirus (COVID-19) Vaccine Market Size and Prospect (2022-2028)
4.6 South America
4.6.1 Key Companies of Novel Coronavirus (COVID-19) Vaccine in South America
4.6.2 Current Situation and Forecast of Novel Coronavirus (COVID-19) Vaccine in South America
4.6.3 South America Novel Coronavirus (COVID-19) Vaccine Market Size and Prospect (2022-2028)
4.7 Middle East & Africa
4.7.1 Key Companies of Novel Coronavirus (COVID-19) Vaccine in Middle East & Africa
4.7.2 Current Situation and Forecast of Novel Coronavirus (COVID-19) Vaccine in Middle East & Africa
4.7.3 Middle East & Africa Novel Coronavirus (COVID-19) Vaccine Market Size and Prospect (2022-2028)
5 Market Size Segment by Type
5.1 Global Novel Coronavirus (COVID-19) Vaccine Market Forecast by Type (2022-2028)
5.2 Global Novel Coronavirus (COVID-19) Vaccine Market Share Forecast by Type (2022-2028)
6 Market Size Segment by Application
6.1 Global Novel Coronavirus (COVID-19) Vaccine Market Forecast by Application (2022-2028)
6.2 Global Novel Coronavirus (COVID-19) Vaccine Market Share Forecast by Application (2022-2028)
7 Research Findings and Conclusion
8 Appendix
8.1 Methodology
8.2 Research Process and Data Source
8.3 Disclaimer

List of Tables

List of Tables
Table 1. Global Novel Coronavirus (COVID-19) Vaccine Revenue by Type, (USD Million), 2022 VS 2028
Table 2. Global Novel Coronavirus (COVID-19) Vaccine Revenue by Application, (USD Million), 2022 VS 2028
Table 3. Inovio Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 4. Inovio Pharmaceuticals Major Business
Table 5. Inovio Pharmaceuticals Novel Coronavirus (COVID-19) Vaccine Product and Solutions
Table 6. Takis Biotech (Evvivax) Corporate Information, Head Office, and Major Competitors
Table 7. Takis Biotech (Evvivax) Major Business
Table 8. Takis Biotech (Evvivax) Novel Coronavirus (COVID-19) Vaccine Product and Solutions
Table 9. Zydus Cadila Corporate Information, Head Office, and Major Competitors
Table 10. Zydus Cadila Major Business
Table 11. Zydus Cadila Novel Coronavirus (COVID-19) Vaccine Product and Solutions
Table 12. Codagenix, Inc. Corporate Information, Head Office, and Major Competitors
Table 13. Codagenix, Inc. Major Business
Table 14. Codagenix, Inc. Novel Coronavirus (COVID-19) Vaccine Product and Solutions
Table 15. GeoVax, Inc. Corporate Information, Head Office, and Major Competitors
Table 16. GeoVax, Inc. Major Business
Table 17. GeoVax, Inc. Novel Coronavirus (COVID-19) Vaccine Product and Solutions
Table 18. Bravovax Corporate Information, Head Office, and Major Competitors
Table 19. Bravovax Major Business
Table 20. Bravovax Novel Coronavirus (COVID-19) Vaccine Product and Solutions
Table 21. Janssen Pharmaceutical Companies Corporate Information, Head Office, and Major Competitors
Table 22. Janssen Pharmaceutical Companies Major Business
Table 23. Janssen Pharmaceutical Companies Novel Coronavirus (COVID-19) Vaccine Product and Solutions
Table 24. Altimmune Corporate Information, Head Office, and Major Competitors
Table 25. Altimmune Major Business
Table 26. Altimmune Novel Coronavirus (COVID-19) Vaccine Product and Solutions
Table 27. Vaxart Corporate Information, Head Office, and Major Competitors
Table 28. Vaxart Major Business
Table 29. Vaxart Novel Coronavirus (COVID-19) Vaccine Product and Solutions
Table 30. CanSino Biologics Corporate Information, Head Office, and Major Competitors
Table 31. CanSino Biologics Major Business
Table 32. CanSino Biologics Novel Coronavirus (COVID-19) Vaccine Product and Solutions
Table 33. ExpreS2ion Biotechnologies ApS Corporate Information, Head Office, and Major Competitors
Table 34. ExpreS2ion Biotechnologies ApS Major Business
Table 35. ExpreS2ion Biotechnologies ApS Novel Coronavirus (COVID-19) Vaccine Product and Solutions
Table 36. Clover Biopharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 37. Clover Biopharmaceuticals Major Business
Table 38. Clover Biopharmaceuticals Novel Coronavirus (COVID-19) Vaccine Product and Solutions
Table 39. GSK Corporate Information, Head Office, and Major Competitors
Table 40. GSK Major Business
Table 41. GSK Novel Coronavirus (COVID-19) Vaccine Product and Solutions
Table 42. Vaxil Bio Ltd. Corporate Information, Head Office, and Major Competitors
Table 43. Vaxil Bio Ltd. Major Business
Table 44. Vaxil Bio Ltd. Novel Coronavirus (COVID-19) Vaccine Product and Solutions
Table 45. Generex Corporate Information, Head Office, and Major Competitors
Table 46. Generex Major Business
Table 47. Generex Novel Coronavirus (COVID-19) Vaccine Product and Solutions
Table 48. Novavax, Inc. Corporate Information, Head Office, and Major Competitors
Table 49. Novavax, Inc. Major Business
Table 50. Novavax, Inc. Novel Coronavirus (COVID-19) Vaccine Product and Solutions
Table 51. Sanofi Pasteur Corporate Information, Head Office, and Major Competitors
Table 52. Sanofi Pasteur Major Business
Table 53. Sanofi Pasteur Novel Coronavirus (COVID-19) Vaccine Product and Solutions
Table 54. Baylor Corporate Information, Head Office, and Major Competitors
Table 55. Baylor Major Business
Table 56. Baylor Novel Coronavirus (COVID-19) Vaccine Product and Solutions
Table 57. iBio, Inc. Corporate Information, Head Office, and Major Competitors
Table 58. iBio, Inc. Major Business
Table 59. iBio, Inc. Novel Coronavirus (COVID-19) Vaccine Product and Solutions
Table 60. Moderna, Inc. Corporate Information, Head Office, and Major Competitors
Table 61. Moderna, Inc. Major Business
Table 62. Moderna, Inc. Novel Coronavirus (COVID-19) Vaccine Product and Solutions
Table 63. Curevac Corporate Information, Head Office, and Major Competitors
Table 64. Curevac Major Business
Table 65. Curevac Novel Coronavirus (COVID-19) Vaccine Product and Solutions
Table 66. ImmunoPrecise Corporate Information, Head Office, and Major Competitors
Table 67. ImmunoPrecise Major Business
Table 68. ImmunoPrecise Novel Coronavirus (COVID-19) Vaccine Product and Solutions
Table 69. Global Novel Coronavirus (COVID-19) Vaccine Revenue (USD Million) by Players (2022 & 2028)
Table 70. Global Novel Coronavirus (COVID-19) Vaccine Revenue Share by Players (2022 & 2028)
Table 71. Novel Coronavirus (COVID-19) Vaccine Players Head Office, Products and Services Provided
Table 72. Novel Coronavirus (COVID-19) Vaccine Mergers & Acquisitions in the Past Five Years
Table 73. Novel Coronavirus (COVID-19) Vaccine New Entrants and Expansion Plans
Table 74. Global Market Novel Coronavirus (COVID-19) Vaccine Revenue (USD Million) Comparison by Region (2022 VS 2028)
Table 75. Global Novel Coronavirus (COVID-19) Vaccine Revenue Market Share by Region (2022-2028)
Table 76. Key Companies of Novel Coronavirus (COVID-19) Vaccine in North America
Table 77. Current Situation and Forecast of Novel Coronavirus (COVID-19) Vaccine in North America
Table 78. Key Companies of Novel Coronavirus (COVID-19) Vaccine in Europe
Table 79. Current Situation and Forecast of Novel Coronavirus (COVID-19) Vaccine in Europe
Table 80. Key Companies of Novel Coronavirus (COVID-19) Vaccine in Asia-Pacific
Table 81. Current Situation and Forecast of Novel Coronavirus (COVID-19) Vaccine in Asia-Pacific
Table 82. Key Companies of Novel Coronavirus (COVID-19) Vaccine in China
Table 83. Key Companies of Novel Coronavirus (COVID-19) Vaccine in Japan
Table 84. Key Companies of Novel Coronavirus (COVID-19) Vaccine in South Korea
Table 85. Key Companies of Novel Coronavirus (COVID-19) Vaccine in South America
Table 86. Current Situation and Forecast of Novel Coronavirus (COVID-19) Vaccine in South America
Table 87. Key Companies of Novel Coronavirus (COVID-19) Vaccine in Middle East & Africa
Table 88. Current Situation and Forecast of Novel Coronavirus (COVID-19) Vaccine in Middle East & Africa
Table 89. Global Novel Coronavirus (COVID-19) Vaccine Revenue Forecast by Type (2022-2028)
Table 90. Global Novel Coronavirus (COVID-19) Vaccine Revenue Forecast by Application (2022-2028)
List of Figures
Figure 1. Novel Coronavirus (COVID-19) Vaccine Picture
Figure 2. Global Novel Coronavirus (COVID-19) Vaccine Revenue Market Share by Type in 2028
Figure 3. DNA
Figure 4. RNA
Figure 5. Others
Figure 6. Novel Coronavirus (COVID-19) Vaccine Revenue Market Share by Application in 2028
Figure 7. Mild Symptom Patient Picture
Figure 8. Critically Ill Patient Picture
Figure 9. Global Novel Coronavirus (COVID-19) Vaccine Market Size, (USD Million): 2022 VS 2028
Figure 10. Global Novel Coronavirus (COVID-19) Vaccine Revenue and Forecast (2022-2028) & (USD Million)
Figure 11. Novel Coronavirus (COVID-19) Vaccine Market Drivers
Figure 12. Novel Coronavirus (COVID-19) Vaccine Market Restraints
Figure 13. Novel Coronavirus (COVID-19) Vaccine Market Trends
Figure 14. Inovio Pharmaceuticals Recent Developments and Future Plans
Figure 15. Takis Biotech (Evvivax) Recent Developments and Future Plans
Figure 16. Zydus Cadila Recent Developments and Future Plans
Figure 17. Codagenix, Inc. Recent Developments and Future Plans
Figure 18. GeoVax, Inc. Recent Developments and Future Plans
Figure 19. Bravovax Recent Developments and Future Plans
Figure 20. Janssen Pharmaceutical Companies Recent Developments and Future Plans
Figure 21. Altimmune Recent Developments and Future Plans
Figure 22. Vaxart Recent Developments and Future Plans
Figure 23. CanSino Biologics Recent Developments and Future Plans
Figure 24. ExpreS2ion Biotechnologies ApS Recent Developments and Future Plans
Figure 25. Clover Biopharmaceuticals Recent Developments and Future Plans
Figure 26. GSK Recent Developments and Future Plans
Figure 27. Vaxil Bio Ltd. Recent Developments and Future Plans
Figure 28. Generex Recent Developments and Future Plans
Figure 29. Novavax, Inc. Recent Developments and Future Plans
Figure 30. Sanofi Pasteur Recent Developments and Future Plans
Figure 31. Baylor Recent Developments and Future Plans
Figure 32. iBio, Inc. Recent Developments and Future Plans
Figure 33. Moderna, Inc. Recent Developments and Future Plans
Figure 34. Curevac Recent Developments and Future Plans
Figure 35. ImmunoPrecise Recent Developments and Future Plans
Figure 36. Global Novel Coronavirus (COVID-19) Vaccine Revenue Market Share by Region (2022-2028)
Figure 37. Global Novel Coronavirus (COVID-19) Vaccine Revenue Market Share by Region in 2028
Figure 38. North America Novel Coronavirus (COVID-19) Vaccine Revenue (USD Million) and Growth Rate (2022-2028)
Figure 39. Europe Novel Coronavirus (COVID-19) Vaccine Revenue (USD Million) and Growth Rate (2022-2028)
Figure 40. Asia-Pacific Novel Coronavirus (COVID-19) Vaccine Revenue (USD Million) and Growth Rate (2022-2028)
Figure 41. South America Novel Coronavirus (COVID-19) Vaccine Revenue (USD Million) and Growth Rate (2022-2028)
Figure 42. Middle East & Africa Novel Coronavirus (COVID-19) Vaccine Revenue (USD Million) and Growth Rate (2022-2028)
Figure 43. Global Novel Coronavirus (COVID-19) Vaccine Market Share Forecast by Type (2022-2028)
Figure 44. Global Novel Coronavirus (COVID-19) Vaccine Market Share Forecast by Application (2022-2028)
Figure 45. Methodology
Figure 46. Research Process and Data Source